Annals of Thoracic Medicine Official publication of the Saudi Thoracic Society, affiliated to King Saud University
 
Search Ahead of print Current Issue Archives Instructions Subscribe e-Alerts Login 
Home Email this article link Print this article Bookmark this page Decrease font size Default font size Increase font size

    Article Cited by others

ORIGINAL ARTICLE

Saudi experience in the management of pulmonary arterial hypertension; the outcome of PAH therapy with the exclusion of chronic parenteral prostacyclin

Idrees Majdy, Alnajashi Khalid, Abdulhameed Jasim, Khan Atika, Batubara Enas, Alotay Abdelmajeed, Fayed Amal, Aldammas Saleh, Alseif Moaad, Alawwad Husam, Abusabaa Yahya, Almobrad Mashael, Kashour Tarek, SAPH The Registry Taskforce

Year : 2015| Volume: 10| Issue : 3 | Page no: 204-211

   This article has been cited by
 
1 Pulmonary hypertension in Saudi Arabia: First data from the SAUDIPH registry with a focus on pulmonary arterial hypertension
Abdullah M. Aldalaan, Sarfraz A. Saleemi, Ihab Weheba, Abeer Abdelsayed, Maha M. Aleid, Fatima Alzubi, Hamdeia Zaytoun, Nadeen Alharbi
Respirology. 2021; 26(1): 92
[Pubmed]  [Google Scholar] [DOI]
2 Long-term outcomes in pulmonary arterial hypertension by functional class: a meta-analysis of randomized controlled trials and observational registries
Nick H. Kim, Micah Fisher, David Poch, Carol Zhao, Mehul Shah, Sonja Bartolome
Pulmonary Circulation. 2020; 10(4): 2045894020
[Pubmed]  [Google Scholar] [DOI]
3 Chronic thromboembolic pulmonary hypertension in Saudi Arabia: preliminary results from the SAUDIPH registry
Abdullah M. Aldalaan, Sarfraz A. Saleemi, Ihab Weheba, Abeer Abdelsayed, Pekka Hämmäinen, Maha M. Aleid, Fatima Alzubi, Hamdeia Zaytoun, Nadeen Alharbi
ERJ Open Research. 2020; 6(2): 00218-2019
[Pubmed]  [Google Scholar] [DOI]

 

Read this article